Outbreaks of infectious diseases, caused by harmful pathogens, can be traced back centuries as the cause of significant morbidity and mortality in humans. The previous century saw two of medicine’s biggest achievements: the introduction of vaccinations to prevent infections and the use of antibiotics to cure infections when they do occur. Preventing and curing infections remain key goals of medicine in providing optimal health for a population. But growing antibiotic resistance and community-acquired infections are on the rise. It’s important to take a closer look at these growing trends.
New one-gallon size now available
Stepping Up as a Resource in Infection Prevention
CHARLOTTE, N.C. – March 1, 2016 - Surface Medical Inc. (“SMI”) and Sealed Air Corporation (NYSE:SEE) announced today that they have entered into a strategic partnership to exclusively distribute the CleanPatch® branded product line in the United States through Sealed Air’s Diversey division.
Sealed Air Corporation (NYSE: SEE) announced July 2, that it has completed an acquisition of Virox Technologies’ Accel® brand and its related healthcare businesses in the United States and Canada.
The acquired assets include the brand, the current healthcare business and existing customer relationships. Through its Diversey business, Sealed Air has had a long standing exclusive, global relationship with Virox and this new arrangement will enhance Diversey’s marketing of Virox’s proprietary Accelerated Hydrogen Peroxide® (AHP®) technology.
One-step disinfectant cleaner offers protection against harmful pathogens
STURTEVANT, WISCONSIN – March 17, 2014 – Sealed Air’s Diversey Division today introduced Oxivir Plus to the Canadian market. At a 1:40 dilution, it disinfects hard non-porous surfaces in just five minutes. Powered by AHP® technology, Oxivir Plus is effective against pathogenic organisms such as bacteria, viruses and fungi that can cause healthcare-associated infections (HAIs), the fourth leading cause of death in Canada.